Gustav Mahlerplein 3
1082 MS Amsterdam
INKEF Capital’s mission is to invest in the Netherlands in
companies with the potential to develop new technologies
into commercially successful products and markets.
They aim to generate returns that are commensurate with
the high risk and long term character of these investments.
In this endeavor, they build upon the long term investment
perspective of ABP, INKEF Capital’s shareholder.
|Lanthio Pharma ||11/12||Series A||€4.8M||2|
Lanthio Pharma Raises €4.8M in First Close of Series A funding (finsmes.com)